Actively Recruiting
Clinical Trial of BT02 in Patients With Advanced Solid Tumors
Led by Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Updated on 2024-12-27
60
Participants Needed
1
Research Sites
48 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A First-in-Human, Open Label, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Antitumor Activity of BT02 in Patients with Advanced Solid Tumors
CONDITIONS
Official Title
Clinical Trial of BT02 in Patients With Advanced Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or older at the time of signing the informed consent form, male or female
- Histologically or cytologically confirmed diagnosis of advanced solid tumor
- Adequate organ and blood function
- At least measurable or evaluable tumor lesion in Phase I and measurable lesion in Phase II per RECIST 1.1
- ECOG performance status of 0 or 1
- Life expectancy of at least 3 months
- Ability and willingness to comply with follow-up visits
You will not qualify if you...
- Prior systemic anti-cancer therapy
- Active or documented autoimmune disease within the past 2 years
- History of significant cardiovascular disease
- Significant acute or chronic infections
- Residual toxicities from previous anti-cancer treatments not improved to Grade 3 severity
- Any prior Grade 3 or higher immune-related adverse event from immunotherapy
- Unstable brain or meningeal metastases with symptoms
- Mental disorders or poor compliance
- Known alcohol or drug abuse
- Other severe systemic diseases or conditions deemed unsuitable by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cancer Institute and Hospital
Beijing, Biejing, China, 1000021
Actively Recruiting
Research Team
N
Ning Li, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here